Lip fillers have become one of the most popular non-surgical cosmetic procedures worldwide, promising fuller, well-defined lips with minimal downtime. However, along with their popularity, it has also ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...

Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...

The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.

The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

IVF hormone injections are an advanced fertility treatment that helps your ovaries make more eggs, supporting your IVF cycles and achieving healthy eggs. Doctors administer these hormonal injections ...

As we venture into the new year, the perennial battle against winter ailments such as colds and flu is in full swing. With a so-called 'super flu' circulating as January commences, many are pondering ...

Mounjaro (tirzepatide) is a prescription medication used with diet and exercise to help adults with type 2 diabetes manage blood sugar levels. Mounjaro comes as an injection given under the skin.

Lokelma (sodium zirconium cyclosilicate) is a prescription drug used to treat high blood potassium levels. Examples of side effects of Lokelma include fluid swelling in areas of the body and low blood ...

With 28% of UK adults now classified as obese - and a further 36% overweight - it’s no wonder weight-loss injections have exploded in popularity. An estimated 1.5 million people are already using them ...